PT - JOURNAL ARTICLE AU - Bansilan, Norvin P. AU - Rabajante, Jomar F. TI - Unraveling COVID-19: Descriptive Analytics in a Middle-Income Country, Paving the Path Forward AID - 10.1101/2023.08.16.23294160 DP - 2023 Jan 01 TA - medRxiv PG - 2023.08.16.23294160 4099 - http://medrxiv.org/content/early/2023/08/20/2023.08.16.23294160.short 4100 - http://medrxiv.org/content/early/2023/08/20/2023.08.16.23294160.full AB - The outbreak of COVID-19 unleashed an unprecedented global pandemic, leaving a profound impact on lives and economies worldwide. Recognizing its severity, the World Health Organization swiftly declared it a public health emergency of international concern. Tragically, the Philippines reported the first death case outside China, leading to a surge in cases following the first instance of local transmission. In response to this crisis, collaborative efforts have been underway to control the disease and minimize its health and socio-economic impacts. The COVID-19 epidemic curve holds vital insights into the history of exposure, transmission, testing, tracing, social distancing measures, community lockdowns, quarantine, isolation, and treatment, offering a comprehensive perspective on the nation’s response. One approach to gaining crucial insights is through meticulous analysis of available datasets, empowering us to inform future strategies and responses effectively. This paper aims to provide descriptive data analytics of the COVID-19 pandemic in the Philippines, summarizing the country’s fight by visualizing epidemiological and mobility datasets, revisiting scientific papers and news articles, and creating a timeline of the key issues faced during the pandemic. By leveraging these multifaceted analyses, policymakers and health authorities can make informed decisions to enhance preparedness, expand inter-agency cooperation, and combat future public health crises effectively. This study seeks to serve as a valuable resource, guiding nations worldwide in comprehending and responding to the challenges posed by COVID-19 and beyond.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:World Health Organization (https://covid19.who.int/); Department of Health of the Philippines (https://doh.gov.ph/covid19tracker); Our World in Data (https://ourworldindata.org/covid-vaccinations); Google, Covid-19 community mobility reports, (https://www.google.com/covid19/mobility/)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at World Health Organization (https://covid19.who.int/); Department of Health of the Philippines (https://doh.gov.ph/covid19tracker); Our World in Data (https://ourworldindata.org/covid-vaccinations); Google, Covid-19 community mobility reports, (https://www.google.com/covid19/mobility/)